Rockwell Medical (RMTI) Cash & Current Investments (2010 - 2026)

Rockwell Medical (RMTI) has 17 years of Cash & Current Investments data on file, last reported at $23.9 million in Q1 2026.

• Quarterly Cash & Current Investments rose 37.85% year-over-year to $23.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.9 million (up 37.85% YoY) and the FY2025 annual result came in at $25.0 million, up 15.72% from the prior year.
• Cash & Current Investments eased to $23.9 million in Q1 2026, from $25.0 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $30.8 million in Q2 2022 to a low of $8.6 million in Q1 2024.
• A 5-year average of $18.4 million and a median of $18.3 million in 2024 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2022 — Cash & Current Investments sank 78.54% — and 2025, when it soared 101.08%.
• Tracing RMTI's Cash & Current Investments over 5 years: stood at $21.5 million in 2022, then plunged by 49.12% to $10.9 million in 2023, then jumped by 97.55% to $21.6 million in 2024, then increased by 15.72% to $25.0 million in 2025, then fell by 4.43% to $23.9 million in 2026.
• The last three Cash & Current Investments figures came in at $23.9 million (Q1 2026), $25.0 million (Q4 2025), and $23.7 million (Q3 2025), per Business Quant data.